Cytocidal activities of topoisomerase 1 inhibitors and 5-azacytidine against pheochromocytoma/paraganglioma cells in primary human tumor cultures and mouse cell lines.
There is currently no effective treatment for metastatic pheochromocytomas and paragangliomas. A deficiency in current chemotherapy regimens is that the metastases usually grow very slowly. Drugs that target dividing tumor cells have therefore had limited success. To improve treatment, new strategie...
Main Authors: | James F Powers, Parimal G Korgaonkar, Stephanie Fliedner, Alessio Giubellino, Karel Pacak, G Gary Sahagian, Arthur S Tischler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3917832?pdf=render |
Similar Items
-
Correction: Cytocidal Activities of Topoisomerase 1 Inhibitors and 5-Azacytidine against Pheochromocytoma/Paraganglioma Cells in Primary Human Tumor Cultures and Mouse Cell Lines
by: The Staff
Published: (2014-01-01) -
Correction: Cytocidal Activities of Topoisomerase 1 Inhibitors and 5-Azacytidine against Pheochromocytoma/Paraganglioma Cells in Primary Human Tumor Cultures and Mouse Cell Lines.
Published: (2014-01-01) -
Pheochromocytoma (PHEO) and Paraganglioma (PGL)
by: Karel Pacak, et al.
Published: (2019-09-01) -
Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
by: Ying Pang, et al.
Published: (2019-03-01) -
New insights on the pathogenesis of paraganglioma and pheochromocytoma [version 1; referees: 2 approved]
by: Vitaly Kantorovich, et al.
Published: (2018-09-01)